Breast cancer: FDA reporting patterns
92,810 FDA FAERS reports mention Breast cancer. 92,113 reports have a serious outcome flag.
Medicines named as suspect
- Ranitidine: 45,671 reports
- Estrogens Conjugated: 12,187 reports
- Medroxyprogesterone: 11,163 reports
- Estradiol: 2,494 reports
- Etanercept: 2,134 reports
- Infliximab: 1,645 reports
- Letrozole: 1,578 reports
- Interferon Beta-1a: 1,412 reports
- Adalimumab: 1,399 reports
- Methotrexate: 1,100 reports
- Norethindrone: 883 reports
- Ribociclib: 860 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.